ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
ABVC BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.91−0.01 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $23.71M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2023(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jul 25, 2023 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 28, 2019(first seen in filings) | 1-for-18.5 reverse | Earlier per-share figures multiplied by 18.5 |
| May 8, 2019 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Jan 12, 2017(first seen in filings) | 52-for-1 | Earlier per-share figures divided by 52 |
| Aug 13, 2015 | 1-for-5000 reverse | Earlier per-share figures multiplied by 5000 |
| Feb 18, 2011 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |